Trial Profile
Practical evaluation of SCr and uric acid variation for hepatitis C virus infection using a telaprevir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- 03 Sep 2013 New trial record